EDGAR Filing Documents for 0001144204-16-111756

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:

SEC Accession No. 0001144204-16-111756

Filing Date

2016-07-06

Accepted

2016-07-06 17:29:23

Documents

Period of Report

2016-07-06

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 6-K	v443792_6k.htm	6-K	10831
2	MATERIAL CHANGE REPORT DATED JULY 6, 2016	v443792_ex99-1.htm	EX-99.1	27061
	Complete submission text file	0001144204-16-111756.txt		38896

Mailing Address 101 COLLEGE STREET SUITE 220 TORONTO A6 M5G 1L7

Business Address 101 COLLEGE STREET SUITE 220 TORONTO A6 M5G 1L7 416-260-7770

Transition Therapeutics Inc. (Filer) CIK: 0001399250 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 001-33514 | Film No.: 161754775
SIC: 2833 Medicinal Chemicals & Botanical Products